Stocks and InvestingStocks and Investing
Mon, March 4, 2024
Fri, March 1, 2024

Ed Arce Maintained (AKRO) at Strong Buy with Increased Target to $43 on, Mar 1st, 2024


Published on 2024-10-28 09:22:09 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Increased Target from $40 to $43 on, Mar 1st, 2024.

Ed, nor any peers, have made any analyst calls on AKRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30